Justin Larkin is a partner on the Bio investing team, focusing primarily on health technology companies that are transforming the way patients, payors, and providers experience and deliver healthcare.
Prior to joining a16z, Justin led the Strategy and Ops org at Verily (formerly known as Google Life Sciences), working across their portfolio of care delivery, software analytics, and med device business lines. Prior to that, Justin was a co-founder and the product / clinical lead at Wellsheet, a venture-backed health IT company focused on using ML to streamline physician workflows within electronic health records.
Justin holds an MD from the University of Pennsylvania where he was a John Morgan Scholar and a founding member of PennHealthX, an endowed program for cross-disciplinary training in clinical medicine and health technology / entrepreneurship. Justin also holds an MBA from the Stanford Graduate School of Business, as well as a BS / BA from BYU in Developmental Biology and Portuguese, respectively.